Axonal and neuromuscular synaptic phenotypes in WldS, SOD1G93A and ostes mutant mice identified by fiber-optic confocal microendoscopy

Molecular and Cellular Neuroscience

Volumn 42, Issue 4, 2009, Pages 296-307

  Wong, Frances ^a,b   Fan, Li ^a   Wells, Sara ^b   Hartley, Robert ^a   Mackenzie, Francesca E ^b   Oyebode, Oyinlola ^a   Brown, Rosalind ^a   Thomson, Derek ^a   Coleman, Michael P ^c   Blanco, Gonzalo ^b   Ribchester, Richard R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MRC MAMMALIAN GENETICS UNIT   (United Kingdom)

^c BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLNITROSOUREA; YELLOW FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; FIBEROPTIC CONFOCAL MICROENDOSCOPY; FIBERSCOPE ENDOSCOPY; HETEROZYGOTE; HOMOZYGOTE; IMAGE ANALYSIS; IN VIVO STUDY; INDUCED MUTATION; INHERITANCE; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; MOUSE STRAIN; NERVE DEGENERATION; NERVE ENDING; NERVE FIBER DEGENERATION; NERVE FIBER REGENERATION; NERVE INJURY; NEUROMUSCULAR SYNAPSE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCIATIC NERVE;

ANIMALS; AXONS; DISEASE MODELS, ANIMAL; ENDOSCOPY; FEMALE; FIBER OPTIC TECHNOLOGY; HUMANS; LUMINESCENT PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MOTOR NEURON DISEASE; MOTOR NEURONS; MUTATION; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEUROMUSCULAR JUNCTION; PHENOTYPE; SUPEROXIDE DISMUTASE; SYNAPSES; WALLERIAN DEGENERATION;

ANIMALIA; MUS; WALLERIA;

EID: 70350769110     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2009.08.002     Document Type: Article

References (74)

1. Acevedo-Arozena A., Wells S., Potter P., Kelly M., Cox R.D., and Brown S.D. ENU mutagenesis, a way forward to understand gene function. Annu. Rev. Genomics Hum. Genet. 9 (2008) 49-69
2. Alexander G.M., Erwin K.L., Byers N., Deitch J.S., Augelli B.J., Blankenhorn E.P., and Heiman-Patterson T.D. Effect of transgene copy number on survival in the G93A SOD1 transgenic mouse model of ALS. Brain Res. 130 (2004) 7-15
3. Balice-Gordon R.J., and Lichtman J.W. In vivo visualization of the growth of pre- and postsynaptic elements of neuromuscular junctions in the mouse. J. Neurosci. 10 (1990) 894-908
4. Barretto R.P., Messerschmidt B., and Schnitzer M.J. In vivo fluorescence imaging with high-resolution microlenses. Nat. Methods 6 (2009) 511-512
5. Beirowski B., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R., and Coleman M.P. The progressive nature of Wallerian degeneration in wild-type and slow Wallerian degeneration (WldS) nerves. BMC Neurosci. 6 (2005) 6
6. Beirowski B., Babetto E., Gilley J.F.M., Conforti L., Janeckova L., Magni G., Ribchester R., and Coleman M. Non-nuclear WldS determines its neuroprotective efficacy for axons and synapses. J Neurosci. 29 (2009) 653-668
7. Beirowski B., Berek L., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R., and Coleman M.P. Quantitative and qualitative analysis of Wallerian degeneration using restricted axonal labelling in YFP-H mice. J. Neurosci. Methods 134 (2004) 23-35
8. Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol. Dis. 26 (2007) 1-13
9. Bendszus M., and Stoll G. Technology insight: visualizing peripheral nerve injury using MRI. Nat. Clin. Pract. 1 (2005) 45-53
10. Bridge K.E., Berg N., Adalbert R., Babetto E., Dias T., Spillantini M.G., Ribchester R.R., and Coleman M.P. Late onset distal axonal swelling in YFP-H transgenic mice. Neurobiol. Aging (2007)
11. Bruijn L.I., and Cleveland D.W. Mechanisms of selective motor neuron death in ALS: insights from transgenic mouse models of motor neuron disease. Neuropathol. Appl. Neurobiol. 22 (1996) 373-387
12. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
13. Carpinelli M.R., Hilton D.J., Metcalf D., Antonchuk J.L., Hyland C.D., Mifsud S.L., Di Rago L., Hilton A.A., Willson T.A., Roberts A.W., Ramsay R.G., Nicola N.A., and Alexander W.S. Suppressor screen in Mpl-/- mice: c-Myb mutation causes supraphysiological production of platelets in the absence of thrombopoietin signaling. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 6553-6558
14. Coleman M.P., Conforti L., Buckmaster E.A., Tarlton A., Ewing R.M., Brown M.C., Lyon M.F., and Perry V.H. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9985-9990
15. Conforti L., Fang G., Beirowski B., Wang M.S., Sorci L., Asress S., Adalbert R., Silva A., Bridge K., Huang X.P., Magni G., Glass J.D., and Coleman M.P. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration. Cell Death Differ. 14 (2007) 116-127
16. Conforti L., Tarlton A., Mack T.G., Mi W., Buckmaster E.A., Wagner D., Perry V.H., and Coleman M.P. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 11377-11382
17. Conforti L., Wilbrey A., Morreale G., Janeckova L., Beirowski B., Adalbert R., Mazzola F., Di Stefano M., Hartley R., Babetto E., Smith T., Gilley J., Billington R.A., Genazzani A.A., Ribchester R.R., Magni G., and Coleman M. Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J. Cell Biol. 184 (2009) 491-500
18. Cook M.C., Vinuesa C.G., and Goodnow C.C. ENU-mutagenesis: insight into immune function and pathology. Curr. Opin. Immunol. 18 (2006) 627-633
19. David G., Nguyen K., and Barrett E.F. Early vulnerability to ischemia/reperfusion injury in motor terminals innervating fast muscles of SOD1-G93A mice. Exp. Neurol. 204 (2007) 411-420
20. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., and Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28 (2000) 41-51
21. Ferri A., Sanes J.R., Coleman M.P., Cunningham J.M., and Kato A.C. Inhibiting axon degeneration and synapse loss attenuates apoptosis and disease progression in a mouse model of motoneuron disease. Curr. Biol. 13 (2003) 669-673
22. Fischer L.R., Culver D.G., Davis A.A., Tennant P., Wang M., Coleman M., Asress S., Adalbert R., Alexander G.M., and Glass J.D. The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiol. Dis. 19 (2005) 293-300
23. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., and Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185 (2004) 232-240
24. Frey D., Schneider C., Xu L., Borg J., Spooren W., and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 20 (2000) 2534-2542
25. Gillingwater T.H., and Ribchester R.R. Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse. J. Physiol. 534 (2001) 627-639
26. Gillingwater T.H., and Ribchester R.R. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. J. Neurocytol. 32 (2003) 863-881
27. Gillingwater T.H., Thomson D., Mack T.G., Soffin E.M., Mattison R.J., Coleman M.P., and Ribchester R.R. Age-dependent synapse withdrawal at axotomised neuromuscular junctions in Wld(s) mutant and Ube4b/Nmnat transgenic mice. J. Physiol. 543 (2002) 739-755
28. Gillingwater T.H., Wishart T.M., Chen P.E., Haley J.E., Robertson K., MacDonald S.H., Middleton S., Wawrowski K., Shipston M.J., Melmed S., Wyllie D.J., Skehel P.A., Coleman M.P., and Ribchester R.R. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells. Hum. Mol. Genet. 15 (2006) 625-635
29. Godinho S.I., and Nolan P.M. The role of mutagenesis in defining genes in behaviour. Eur. J. Hum. Genet. 14 (2006) 651-659
30. Gondo Y. Trends in large-scale mouse mutagenesis: from genetics to functional genomics. Nat. Rev. Genet. 9 (2008) 803-810
31. Gotz J., Deters N., Doldissen A., Bokhari L., Ke Y., Wiesner A., Schonrock N., and Ittner L.M. A decade of tau transgenic animal models and beyond. Brain Pathol. (Zurich, Switzerland) 17 (2007) 91-103
32. Gotz J., and Ittner L.M. Animal models of Alzheimer's disease and frontotemporal dementia. Nat. Rev. 9 (2008) 532-544
33. Gurney M.E., Pu H., Chiu A.Y., Dal Canto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science (New York, N.Y) 264 (1994) 1772-1775
34. Jackson M., Ganel R., and Rothstein J.D. Models of amyotrophic lateral sclerosis. Current protocols in neuroscience/editorial board. Jacqueline N. Crawley ... [et al Chapter 9, Unit 9 13 (2002)
35. Justice M.J., Carpenter D.A., Favor J., Neuhauser-Klaus A., Hrabe de Angelis M., Soewarto D., Moser A., Cordes S., Miller D., Chapman V., Weber J.S., Rinchik E.M., Hunsicker P.R., Russell W.L., and Bode V.C. Effects of ENU dosage on mouse strains. Mamm. Genome 11 (2000) 484-488
36. Kariya S., Mauricio R., Dai Y., and Monani U.R. The neuroprotective factor Wld(s) fails to mitigate distal axonal and neuromuscular junction (NMJ) defects in mouse models of spinal muscular atrophy. Neurosci. Lett. (2008)
37. Kieran D., Hafezparast M., Bohnert S., Dick J.R., Martin J., Schiavo G., Fisher E.M., and Greensmith L. A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J. Cell Biol. 169 (2005) 561-567
38. Llewellyn M.E., Barretto R.P., Delp S.L., and Schnitzer M.J. Minimally invasive high-speed imaging of sarcomere contractile dynamics in mice and humans. Nature 454 (2008) 784-788
39. Lunn E.R., Brown M.C., and Perry V.H. The pattern of axonal degeneration in the peripheral nervous system varies with different types of lesion. Neuroscience 35 (1990) 157-165
40. Lunn E.R., Perry V.H., Brown M.C., Rosen H., and Gordon S. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1 (1989) 27-33
41. Lyon M.F., Ogunkolade B.W., Brown M.C., Atherton D.J., and Perry V.H. A gene affecting Wallerian nerve degeneration maps distally on mouse chromosome 4. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 9717-9720
42. Mack T.G., Reiner M., Beirowski B., Mi W., Emanuelli M., Wagner D., Thomson D., Gillingwater T., Court F., Conforti L., Fernando F.S., Tarlton A., Andressen C., Addicks K., Magni G., Ribchester R.R., Perry V.H., and Coleman M.P. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene. Nat. Neurosci. 4 (2001) 1199-1206
43. Mackenzie F., Ribchester R., Gillingwater T., Powles-Glover N., Gale R., Wong F., Arkell R., and Blanco G. Identification and characterisation of a candidate gene for ostes, a novel mouse mutant showing muscle denervation and atrophy. Amyotroph. Lateral Scler. 8 Supplement 1 (2007) 1
44. Mackenzie F.E., Romero R., Wong F., Williams D., Gillingwater T., Hilton H., Dick J., Riddoch-Contereras J., Ireson L., Powles-Glover N., Riley G., Underhill P., Hough T., Arkell R., Greensmith L., Ribchester R.R., and Blanco G. Upregulation of PKD1L2 provokes a complex neuromuscular disease in the mouse. Hum. Mol. Genet. 18 (2001) 3553-3566
45. Mi W., Beirowski B., Gillingwater T.H., Adalbert R., Wagner D., Grumme D., Osaka H., Conforti L., Arnhold S., Addicks K., Wada K., Ribchester R.R., and Coleman M.P. The slow Wallerian degeneration gene, WldS, inhibits axonal spheroid pathology in gracile axonal dystrophy mice. Brain 128 (2005) 405-416
46. Misgeld T., and Kerschensteiner M. In vivo imaging of the diseased nervous system. Nat. Rev. 7 (2006) 449-463
47. Nolan P.M., Peters J., Vizor L., Strivens M., Washbourne R., Hough T., Wells C., Glenister P., Thornton C., Martin J., Fisher E., Rogers D., Hagan J., Reavill C., Gray I., Wood J., Spurr N., Browne M., Rastan S., Hunter J., and Brown S.D. Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resource. Mamm. Genome 11 (2000) 500-506
48. Olson M. Enrichment of super-sized resequencing targets from the human genome. Nat. Methods 4 (2007) 891-892
49. Pan Y.A., Misgeld T., Lichtman J.W., and Sanes J.R. Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo. J. Neurosci. 23 (2003) 11479-11488
50. Pelled G., Dodd S.J., and Koretsky A.P. Catheter confocal fluorescence imaging and functional magnetic resonance imaging of local and systems level recovery in the regenerating rodent sciatic nerve. NeuroImage 30 (2006) 847-856
51. Perry V.H., Brown M.C., Lunn E.R., Tree P., and Gordon S. Evidence that very slow Wallerian degeneration in C57BL/Ola mice is an intrinsic property of the peripheral nerve. Eur. J. Neurosci. 2 (1990) 802-808
52. Perry V.H., Brown M.C., and Tsao J.W. The effectiveness of the gene which slows the rate of Wallerian degeneration in C57BL/Ola mice declines with age. Eur. J. NeuroSci. 4 (1992) 1000-1002
53. Perry V.H., Lunn E.R., Brown M.C., Cahusac S., and Gordon S. Evidence that the rate of Wallerian degeneration is controlled by a single autosomal dominant gene. Eur. J. Neurosci. 2 (1990) 408-413
54. Pun S., Santos A.F., Saxena S., Xu L., and Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 9 (2006) 408-419
55. Ravits J., Laurie P., Fan Y., and Moore D.H. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68 (2007) 1576-1582
56. Ribchester R.R., Tsao J.W., Barry J.A., Asgari-Jirhandeh N., Perry V.H., and Brown M.C. Persistence of neuromuscular junctions after axotomy in mice with slow Wallerian degeneration (C57BL/WldS). Eur. J. Neurosci. 7 (1995) 1641-1650
57. Rose Jr. F.F., Meehan P.W., Coady T.H., Garcia V.B., Garcia M.L., and Lorson C.L. The Wallerian degeneration slow (Wld(s)) gene does not attenuate disease in a mouse model of spinal muscular atrophy. Biochem. Biophys. Res. Commun. 375 (2008) 119-123
58. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362 (1993) 59-62
59. Rubio-Aliaga I., Soewarto D., Wagner S., Klaften M., Fuchs H., Kalaydjiev S., Busch D.H., Klempt M., Rathkolb B., Wolf E., Abe K., Zeiser S., Przemeck G.K., Beckers J., and de Angelis M.H. A genetic screen for modifiers of the delta1-dependent notch signaling function in the mouse. Genetics 175 (2007) 1451-1463
60. Samsam M., Mi W., Wessig C., Zielasek J., Toyka K.V., Coleman M.P., and Martini R. The Wlds mutation delays robust loss of motor and sensory axons in a genetic model for myelin-related axonopathy. J. Neurosci. 23 (2003) 2833-2839
61. Schaefer A.M., Sanes J.R., and Lichtman J.W. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490 (2005) 209-219
62. Schnabel J. Neuroscience: standard model. Nature 454 (2008) 682-685
63. Scott S., Kranz J.E., Cole J., Lincecum J.M., Thompson K., Kelly N., Bostrom A., Theodoss J., Al-Nakhala B.M., Vieira F.G., Ramasubbu J., and Heywood J.A. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph. Lateral Scler. 9 (2008) 4-15
64. Tobina T., Nakashima H., Mori S., Abe M., Kumahara H., Yoshimura E., Nishida Y., Kiyonaga A., Shono N., and Tanaka H. The utilization of a biopsy needle to obtain small muscle tissue specimens to analyze the gene and protein expression. J. Surg. Res. 154 (2009) 252-257
65. Turner B.J., and Talbot K. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS. Prog. Neurobiol. 85 (2008) 94-134
66. Vande Velde C., Garcia M.L., Yin X., Trapp B.D., and Cleveland D.W. The neuroprotective factor Wlds does not attenuate mutant SOD1-mediated motor neuron disease. Neuromolecular Med. 5 (2004) 193-203
67. Veldink J.H., Bar P.R., Joosten E.A., Otten M., Wokke J.H., and van den Berg L.H. Sexual differences in onset of disease and response to exercise in a transgenic model of ALS. Neuromuscul. Disord. 13 (2003) 737-743
68. Vincent P., Maskos U., Charvet I., Bourgeais L., Stoppini L., Leresche N., Changeux J.P., Lambert R., Meda P., and Paupardin-Tritsch D. Live imaging of neural structure and function by fibred fluorescence microscopy. EMBO Rep. 7 (2006) 1154-1161
69. Walsh M.K., and Lichtman J.W. In vivo time-lapse imaging of synaptic takeover associated with naturally occurring synapse elimination. Neuron 37 (2003) 67-73
70. Wang M.S., Davis A.A., Culver D.G., and Glass J.D. WldS mice are resistant to paclitaxel (taxol) neuropathy. Ann. Neurol. 52 (2002) 442-447
71. Wilbrey A.L., Haley J.E., Wishart T.M., Conforti L., Morreale G., Beirowski B., Babetto E., Adalbert R., Gillingwater T.H., Smith T., Wyllie D.J., Ribchester R.R., and Coleman M.P. VCP binding influences intracellular distribution of the slow Wallerian degeneration protein, Wld(S). Mol. Cell. Neurosci. 38 (2008) 325-340
72. Winlow W., and Usherwood P.N. Ultrastructural studies of normal and degenerating mouse neuromuscular junctions. J. Neurocytol. 4 (1975) 377-394
73. Wishart T.M., Macdonald S.H., Chen P.E., Shipston M.J., Coleman M.P., Gillingwater T.H., and Ribchester R.R. Design of a novel quantitative PCR (QPCR)-based protocol for genotyping mice carrying the neuroprotective Wallerian degeneration slow (Wlds) gene. Mol. Neurodegeneration 2 (2007) 21
74. Wishart T.M., Paterson J.M., Short D.M., Meredith S., Robertson K.A., Sutherland C., Cousin M.A., Dutia M.B., and Gillingwater T.H. Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol. Cell. Proteomics 6 (2007) 1318-1330